Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 10/20 | 0.41 |
| ▸ | RARB | P10826 | 1/20 | 0.38 |
| ▸ | RARG | P13631 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | FEN1 | P39748 | 5/20 | 0.35 |
| ▸ | ALOX5AP | P20292 | 4/20 | 0.35 |
| ▸ | IDH1 | O75874 | 1/20 | 0.33 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14508289 | 0.93 | PDK2 (0.41) | PDK2RARBRARGRXRA | |
| SCHEMBL14508230 | 0.89 | PDK2 (0.42) | PDK2RARBRARGRXRACLK4 | |
| SCHEMBL14508218 | 0.89 | PDK2 (0.42) | PDK2RARBRARGRXRACLK4 | |
| SCHEMBL14508212 | 0.88 | RARB (0.41) | PDK2RARBRARGRXRACLK4 | |
| SCHEMBL28547043 | 0.87 | PDK2 (0.44) | PDK2CLK4 | |
| SCHEMBL30601319 | 0.87 | PDK2 (0.44) | PDK2CLK4 | |
| SCHEMBL14508155 | 0.86 | PDK2 (0.40) | PDK2RARBRARGRXRA | |
| SCHEMBL14508215 | 0.86 | PDK2 (0.41) | PDK2RARBRARGRXRACLK4 | |
| SCHEMBL14508195 | 0.86 | PDK2 (0.40) | PDK2RARBRARGRXRA | |
| SCHEMBL13388771 | 0.86 | CLK4 (0.42) | PDK2IDH1CLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070122652-A1 | Compound and organic electroluminescent device using same | CANON KABUSHIKI KAISHA (JP) | 2007-05-31 | — | — | US | disclosed |
| US-20070122652-A1 | Compound and organic electroluminescent device using same | CANON KABUSHIKI KAISHA (JP) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070122652-A1 | Compound and organic electroluminescent device using same | OR10J3, LEF1, RPL19 | PDK2 3230/4885RARB 2426/4885RARG 3161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.